These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26489268)

  • 21. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
    Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
    Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Medical indications and effectiveness of the pneumococcal conjugate vaccine].
    Reinert RR
    Laryngorhinootologie; 2006 Apr; 85(4):291-8; quiz 299-300. PubMed ID: 16615030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong.
    Ho PL; Chiu SS; Chow FK; Mak GC; Lau YL
    Vaccine; 2007 Sep; 25(39-40):6837-41. PubMed ID: 17714837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pneumococcal conjugate vaccine for young children.
    Selman S; Hayes D; Perin LA; Hayes WS
    Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on the recommendations for the routine use of pneumococcal conjugate vaccine for infants. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2006 May; 32(ACS-4):1-6. PubMed ID: 16718922
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunisation with a pneumococcal 7-valent conjugate vaccine.
    Dagan R
    Int J Clin Pract; 2002 May; 56(4):287-91. PubMed ID: 12074212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Timing of serotype 1 pneumococcal disease suggests the need for evaluation of a booster dose.
    Klugman KP; Madhi SA; Adegbola RA; Cutts F; Greenwood B; Hausdorff WP
    Vaccine; 2011 Apr; 29(18):3372-3. PubMed ID: 21396901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pneumococcal vaccines for children: a global public health priority.
    Pittet LF; Posfay-Barbe KM
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():25-36. PubMed ID: 22862432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increasing focus on local epidemiology demonstrates potential value of pneumococcal conjugate vaccines in Middle East and North Africa Region.
    Pelton SI
    Vaccine; 2012 Dec; 30 Suppl 6():G1. PubMed ID: 23228351
    [No Abstract]   [Full Text] [Related]  

  • 30. Issues in pneumococcal disease and pneumococcal conjugate vaccines: highlights of the 27th meeting of ESPID, Brussels, Belgium, June 9-13, 2009.
    Adam D
    Vaccine; 2009 Nov; 27(50):7133-7. PubMed ID: 19883868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Capsules, clones, and curious events: pneumococcus under fire from polysaccharide conjugate vaccine.
    Long SS
    Clin Infect Dis; 2005 Jul; 41(1):30-4. PubMed ID: 15937759
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevnar (heptavalent pneumococcal conjugate vaccine): disease prevention in infants and children.
    Shields B
    J Pediatr Health Care; 2001; 15(4):203-8; quiz 209-10. PubMed ID: 11462129
    [No Abstract]   [Full Text] [Related]  

  • 33. Understanding the link between pneumococcal serotypes and invasive disease.
    Soley C; Arguedas A
    Vaccine; 2009 Aug; 27 Suppl 3():C19-21. PubMed ID: 19535183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Conjugated and polysaccharide anti-pneumococcal vaccines].
    Valdez R; Sukster E
    J Pediatr (Rio J); 2005; 81(1):88. PubMed ID: 15742096
    [No Abstract]   [Full Text] [Related]  

  • 35. [New pneumococcal vaccine].
    Gaudelus J
    Bull Acad Natl Med; 2003; 187(8):1477-86; discussion 1486-8. PubMed ID: 15146579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe.
    Rose M; Zielen S
    Expert Rev Vaccines; 2009 Oct; 8(10):1351-64. PubMed ID: 19803758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccine effectiveness of the pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against clinically suspected invasive pneumococcal disease: a cluster-randomised trial.
    Palmu AA; Jokinen J; Nieminen H; Syrjänen R; Ruokokoski E; Puumalainen T; Moreira M; Schuerman L; Borys D; Kilpi TM
    Lancet Respir Med; 2014 Sep; 2(9):717-27. PubMed ID: 25127244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The potential role for protein-conjugate pneumococcal vaccine in adults: what is the supporting evidence?
    Musher DM; Sampath R; Rodriguez-Barradas MC
    Clin Infect Dis; 2011 Mar; 52(5):633-40. PubMed ID: 21292668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Could a single dose of pneumococcal conjugate vaccine in children be effective? Modeling the optimal age of vaccination.
    Barzilay EJ; O'Brien KL; Kwok YS; Hoekstra RM; Zell ER; Reid R; Santosham M; Whitney CG; Feikin DR
    Vaccine; 2006 Feb; 24(7):904-13. PubMed ID: 16203059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pneumococcal infections -- clinical features, prevention and current therapy. Interview with Dr. Endre Ludwig by Anna Radnai].
    Ludwig E
    Orv Hetil; 2013 Jan; 154(3):118-20. PubMed ID: 23315227
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.